Besides the activation of Th2 immunity, soluble IL‐33 plays crucial role in barrier defence, and its disrupted signalling axis has been associated with asthma, rheumatoid arthritis, central nervous diseases and cancer.1, 2, 3 Also, alarmins act to restore tissue homeostasis 4 and it might be assumed that IL‐33 could be involved in promotion of damaged tissue repair. Here, IL33 is linked to asthma.